24 Apr
24Apr

Japanese Shionoji Pharmaceutical Company said on Sunday that new data showed that an experimental treatment for Covid-19 from its production quickly eliminated the virus that causes the disease in an advanced stage of clinical trials. The approval of the regulators in Japan who are currently examining it.

  • The company added that the results released on Sunday showed that the drug improved respiratory symptoms and fever caused by the disease. The company indicated in March that it would launch the third phase of clinical trials for the treatment globally with the support of the US government.
Comments
* The email will not be published on the website.